Trimethoprim-sulfamethoxable-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6

27Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim (TMP)-sulfamethoxazole (SMX) treatment. After the withdrawal of TMP-SMX and the administration of high-dose steroid, these systemic symptoms gradually resolved. During the disease course, the patient showed a transient increase in anti-human herpesvirus (HHV)-6 antibody titers and HHV-6 DNA in the peripheral blood, indicating the reactivation of a latent HHV-6 infection. This is the first case of TMP-SMX-induced hypersensitivity syndrome associated with the reactivation of a latent viral infection. © 2006 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Morimoto, T., Sato, T., Matsuoka, A., Sakamoto, T., Ohta, K., Ando, T., … Oritsu, M. (2006). Trimethoprim-sulfamethoxable-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Internal Medicine, 45(2), 101–105. https://doi.org/10.2169/internalmedicine.45.1352

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free